Ischemic Heart Disease
📧 Sign up to get email alerts when something new happens for Ischemic Heart Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Growth Hormone Deficiency in Chronic Heart Failure: an Observational Study
This completed observational study investigates growth hormone deficiency in patients with chronic heart failure.
-
FDA approval · 2014-02-07FDA Approved: AMMONIA N 13 — Original Application (Washington University School of Medicine)
FDA approved Ammonia N-13 (NH3N13) from Washington University School of Medicine as an original-application radiopharmaceutical for PET imag…
-
CLINICAL_TRIALS research · 2014-02-06Clinical Trial Update: Risk Prediction in Type II Diabetics With Ischemic Heart Disease
This document provides an update on a clinical trial investigating risk prediction in individuals with Type 2 diabetes mellitus and ischemic…
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: Stress Echocardiography Study With Regadenoson [Phase 2]
Phase 2 stress echocardiography study with regadenoson sponsored by Gilead Sciences has been terminated. Status: TERMINATED.
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass [Phase 3]
Phase 3 trial comparing on-pump versus off-pump cardiopulmonary bypass during myocardial revascularization in ischemic heart disease; result…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-01-09FDA Approved: LEXISCAN — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for Lexiscan (regadenoson) from Astellas Pharma US, Inc., updating the labeling for the pharmaco…
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Diagnostic Value of Electrocardiographic St-t Wave Changes in Patients With Chronic Stable Angina
Clinical trial update evaluating the diagnostic value of ECG ST-T wave changes for ischemia in patients with chronic stable angina; current …
-
FDA approval · 2013-12-31FDA Approved: NITROGLYCERIN IN DEXTROSE — Supplemental Application (Baxter Healthcare Company)
FDA approved Baxter Healthcare Company's supplemental NDA for Nitroglycerin in Dextrose, authorizing the nitroglycerin-in-dextrose formulati…
-
CLINICAL_TRIALS trial_result · 2013-12-24Clinical Trial Update: Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) [Phase 2]
A Phase 2 clinical trial evaluating prevention of atherosclerosis and heart disease in patients with systemic lupus erythematosus has comple…
-
FDA approval · 2013-12-09FDA Approved: AMMONIA N 13 — Original Application (Kreitchman PET Center)
FDA approved AMMONIA N-13 as a PET imaging radiotracer under an Original Application for cardiovascular imaging.
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Platelet-Inhibitor Drug Trial in Coronary Angioplasty [Phase 3]
A Phase 3 clinical trial evaluating a platelet-inhibitor drug in patients undergoing coronary angioplasty has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Sleep Disorders and Their Cardiovascular Correlates in Atahualpa. [NA]
A completed clinical trial investigating sleep disorders—insomnia, hypersomnia, and sleep-disordered breathing—and their cardiovascular asso…
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: Comparison of Vascular Access for Radial and Femoral Completion of Diagnostic Cardiac Catheterization [Phase 3]
A Phase 3 clinical trial comparing radial versus femoral vascular access for completing diagnostic cardiac catheterization has completed enr…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: A Phase 1 Study to Assess the Safety,Tolerability, and Pharmacokinetics of GS-6615 in Healthy Subjects [Phase 1]
A Phase 1 study assessed the safety, tolerability, and pharmacokinetics of GS-6615 in healthy subjects and has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: The Danish On-pump, Off-pump Randomization Study (DOORS) [NA]
This clinical trial update notes that the Danish DOORS trial comparing on-pump and off-pump coronary artery bypass procedures has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-01Clinical Trial Update: Effects of Glutamine in Ischemic Heart Disease Patients Following Cardiopulmonary Bypass [Phase 3]
Phase 3 trial evaluating glutamine in patients with ischemic heart disease following cardiopulmonary bypass has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: MYSTAR-5-YEAR: Long-term Follow-up of Patients With Ischemic Heart Disease Treated With Cell Therapy
Long-term follow-up results from the MYSTAR-5-YEAR trial assessing cell therapy in patients with ischemic heart disease after acute myocardi…
-
FDA label_change · 2013-10-16FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Effient (prasugrel hydrochloride) submitted by Cosette Pharmaceuticals, Inc., associated with la…
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia [Phase 4]
Phase 4 trial evaluating eplerenone for chest pain in women with coronary vascular dysfunction and evidence of myocardial ischemia; results …
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: Lumbar Plexus Block Upon the Incidence of Ischemic Cardiovascular Events in Elderly Patients With Hip Fracture [Phase 4]
A Phase 4 trial evaluating whether lumbar plexus block affects the incidence of perioperative ischemic cardiovascular events in elderly pati…
-
FDA approval · 2013-09-12FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2013-08-29Clinical Trial Update: Randomized Clinical Comparison of the Endeavor and the Cypher Coronary Stents in Non-selected Angina Pectoris Patients [Phase 3]
A Phase 3 randomized trial comparing the Endeavor and Cypher coronary stents in non-selected angina patients with ischemic heart disease has…
-
CLINICAL_TRIALS trial_result · 2013-08-28Clinical Trial Update: A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium [Phase 1]
Phase 1 randomized trial evaluating adipose-derived stem cells for non-revascularizable ischemic myocardium has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-20Clinical Trial Update: Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease [Phase 1, Phase 2]
Phase 1/2 safety study evaluating an adenovirus-delivered hepatocyte growth factor for ischemic heart disease, with the current status liste…
-
CLINICAL_TRIALS trial_result · 2013-05-14Clinical Trial Update: Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial [Phase 3]
Phase 3 WARCEF trial comparing warfarin with aspirin in patients with reduced left ventricular ejection fraction found no significant reduct…